“Preventing disease is unquestionably a good thing. But how do we know which risks are real and which are remote? Medical historian Robert Aronowitz discusses the late 20th century turn to risk-based medicine — with widespread screenings and prophylatic treaments — and the role that pharmaceutical companies have played in marketing drugs to prevent possible future afflictions.”